More cancer success with drugs that enlist immune system

U.S. News & World ReportMore cancer success with drugs that enlist immune systemU.S. News & World ReportThe lung cancer study tested Bristol-Myers Squibb's Opdivo (op-DEE-voh), which blocks a protein that prevents the immune system from attacking cancer cells. It worked better than chemotherapy for patients with a form of non-small cell lung cancer that ...New immunotherapy drug outperforms chemotherapy for a form of lung cancerWashington PostBristol's Opdivo cuts risk of lung cancer death for someReutersall 136 news articles »

Share this post